Giles Moss, M. Owen
求助PDF
{"title":"癫痫-使用先进的品牌模式改变市场©","authors":"Giles Moss, M. Owen","doi":"10.3109/J058V16N01_03","DOIUrl":null,"url":null,"abstract":"ABSTRACTIn the pharmaceutical world of today, large, global pharmaceutical companies with their portfolio of “super brands” threaten to dominate to the exclusion of smaller manufacturers. By using sophisticated brand modeling techniques, smaller players can still compete successfully. In the following paper, we explore how UCB has used brand modeling to ensure that its antiepileptic drug, Keppra®, succeeds against competitor brands with much greater resources.","PeriodicalId":16734,"journal":{"name":"Journal of Pharmaceutical Marketing & Management","volume":"105 1","pages":"9-19"},"PeriodicalIF":0.0000,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Epilepsy- Changing a Market by Use of the Advanced Brand Model ©\",\"authors\":\"Giles Moss, M. Owen\",\"doi\":\"10.3109/J058V16N01_03\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"ABSTRACTIn the pharmaceutical world of today, large, global pharmaceutical companies with their portfolio of “super brands” threaten to dominate to the exclusion of smaller manufacturers. By using sophisticated brand modeling techniques, smaller players can still compete successfully. In the following paper, we explore how UCB has used brand modeling to ensure that its antiepileptic drug, Keppra®, succeeds against competitor brands with much greater resources.\",\"PeriodicalId\":16734,\"journal\":{\"name\":\"Journal of Pharmaceutical Marketing & Management\",\"volume\":\"105 1\",\"pages\":\"9-19\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2003-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmaceutical Marketing & Management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3109/J058V16N01_03\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Marketing & Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3109/J058V16N01_03","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
引用
批量引用
Epilepsy- Changing a Market by Use of the Advanced Brand Model ©
ABSTRACTIn the pharmaceutical world of today, large, global pharmaceutical companies with their portfolio of “super brands” threaten to dominate to the exclusion of smaller manufacturers. By using sophisticated brand modeling techniques, smaller players can still compete successfully. In the following paper, we explore how UCB has used brand modeling to ensure that its antiepileptic drug, Keppra®, succeeds against competitor brands with much greater resources.